CDD Webinar: Industry Leaders Discuss the Challenges of Modern Drug Discovery
“Change is the only constant” – Heraclitus of Ephesus
CDD proudly invites you to discuss the underlying dynamics driving
modern drug discovery with selected industry thought leaders.
- Barry Bunin, CEO & President (Collaborative Drug Discovery)
- Daniel Erlanson, President (Carmot Therapeutics)
- Mark Gurney, CEO (Tetra Discovery Partners)
- Henry Johnson, Principal Scientist (Kezar Life Sciences)
- Shirley Louise-May, CDD Advocate (ex-Pfizer)
- Nicholas Skelton, Principal Scientist (Genentech)
As scientists, we hear that the drug discovery landscape has changed, and our industry is evolving at a faster and faster pace. There is a real pressure to “keep up with the Joneses.” So, here’s your chance to “meet the Joneses” of the drug discovery neighborhood.
CDD is bringing together a panel of drug discovery thought leaders for an open discussion on the challenges in modern drug discovery. Join in as the panel discusses how we can learn from the past, make a difference in the present, and impact the future. Together, we’ll explore how innovation provides the key for unlocking a more effective & rewarding drug discovery paradigm!
This is intentionally not a product-focused webinar, but rather a discussion exploring these underlying dynamics driving our fields.
Register now! Although the webinar is at no cost, the experience will be priceless!
Thank You to Our Amazing Sponsors
This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registration, structure activity relationship, chemical inventory, and electronic lab notebook capabilities!
CDD Vault: Drug Discovery Informatics your whole project team will embrace!